<DOC>
	<DOCNO>NCT02089360</DOCNO>
	<brief_summary>Blood sample prospectively take consecutive patient underwent coronary angiogram center , get informed consent patient . Serum level advance glycation end product ( AGEs ) measure clinical feature patient ( include angiographic result ) enter database . Clinical follow-up perform patient , relationship AGEs paitents ' outcome analyze . Further intervention adjust accord result , include clinical basic research lab .</brief_summary>
	<brief_title>Adavanced Glycated Endproducts Development CAD</brief_title>
	<detailed_description>Serum level HMGB1 , HMGB2 , ADAM10 , etc . measure lab animal study design intervene adverse interaction abnormal serum concentration AGEs , etc . bad clinical result .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>patient underwent coronary angiogram suspect coronary artery disease potential percutaneous coronary intervention patient underwent coronary angiogram reason , include presurgery examination patient severe comorbidity , life expectancy less oneyear</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Advanced glycation end product</keyword>
	<keyword>coronary</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>inflammation</keyword>
	<keyword>outcome</keyword>
</DOC>